Daniel Rankin

Daniel Rankin appears at Swedish Orphan Biovitrum AB (publ), a company listed on the Stockholm stock exchange, with 23 filings published from May 24, 2021 to June 15, 2026. The title, in Swedish, designates another member of the company's administrative, management or supervisory bodies. The record holds 7 purchases, 10 sales, 5 grants and one filing of another kind. Purchases total EUR 3,865,865 (median EUR 680,981), sales EUR 5,205,780 (median EUR 460,558), and purchases make up 41% of market trades.

Two days hold both a purchase and a sale. On May 8, 2024, a purchase of EUR 859,102 and a sale of EUR 1,179,460; on February 23, 2023, a purchase of EUR 681,637 and a sale of EUR 899,256. The largest purchase, EUR 861,279, is dated May 13, 2024, and the third-largest sale, EUR 687,405, August 27, 2024.

The year 2024 holds 13 filings, ahead of 2023 (5). The other years hold 1 or 2. Three filings, two of them sales, fall in the last twelve months.

Within 30 days of colleagues at Swedish Orphan Biovitrum AB (publ), Rankin has 15, 15 and 15 own market trades, in that order, all of them in the same direction. Names in order: Guido Oelkers, Henrik Stenqvist and Per Richard Torbjörn Hallberg.